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A B S T R A C T
We report the case of a 31-year-old immunosuppressed, liver transplanted man, with acute measles
infection. The vaccinated patient had been exposed to measles during a known measles epidemic in
public schools in Austria between January and April 2008.Measles infection triggered an episode of acute
liver transplant rejection. The diagnosis of measles infection was made clinically and by serologic tests.
Transplant rejection was diagnosed by liver biopsy. The transplant rejection was treated successfully.
Liver transplant patients are at an increased risk for infection during epidemic outbreaks, even after pre-
transplant vaccination, as immunity may wane over time.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Immunosuppressed patients are at an increased risk formeasles
infection during epidemic outbreaks. Here we report the case of a
liver transplantedmanwho suffered from an acute liver transplant
rejection due to a measles infection during an outbreak in Austria.
1.1. The case
A 31-year-old liver transplanted man presented to his general
practitioner on April 7, 2008. He complained of a stiff neck and
subfebrile temperature of 3-day duration; over the last 2 days, an
erythematous andmaculopapular rash had started on the forehead
and, omitting the extremities, proceeded to the trunk. The rash
persisted for 7 days.
He had received a cadaveric liver transplant in 1995 at the age
of 18 years due to acute liver failure caused by Wilson’s disease.
Histology of the explanted liver had shown a cirrhotic liver with
signs of intrahepatic cholestasis and massive hemosiderin
pigmentation, conﬁrming the diagnosis of Wilson’s disease. No
other relevant medical conditions had been reported. During the
post-transplant period the patient had been regularly followed by
our interdisciplinary outpatient liver transplant clinic. Apart from
minor postoperative complications during the ﬁrst year after
transplantation, no relevant complications had been reported.* Corresponding author.
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therapy with tacrolimus since 1995. Steroids had been tapered in
themonths following transplantation and had ﬁnally been stopped
in 1996. In April 2004, arterial hypertension had been diagnosed
and an antihypertensive treatment with bisoprolol (5 mg daily)
had been initiated.
The patient had worked in public schools in the province of
Salzburg, Austria, since January 2008.
1.2. Investigations
The patient was transferred to our clinic on April 30 due to
elevation of the transaminases and cholestatic parameters.
We saw a 31-year-old man in good general health, with a body
mass index in the normal range (24 kg/m2, 192 cm, 86 kg). The
patient was free of any symptoms. Physical examination was
without any pathologic ﬁndings, there was no exanthema visible
anymore. No fever, night sweats, change of appetite or weight loss
was reported. There was no history of drug intake or change of
medication.
Liver function tests had already been elevated at the time of the
initial presentation at the private practice (April 7, 2008) and had
further increased 3weeks later (Figure 1). Tacrolimus trough levels
were within the therapeutic range.
Abdominal ultrasound showed an enlargement of the liver
(16 cm in medio-clavicular line) and spleen (13  5 cm). No intra-
or extrahepatic cholestasis or other abnormalities of the liver
tissue were seen. There was an orthograde ﬂow in the portal vein
(Vmax 19 cm/s) and in the hepatic artery resistance index (RI 0.6).ses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Liver enzymes: start of rash (1), course of methylprednisolone (2), start of
mycophenolate mofetil (3).
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Hepatitis A, B, C and E serology were repeatedly negative. The
anti-hepatitis B surface antigen (anti-HBs) titer was >260 U/l,
showing protective immunity after vaccination. Cytomegalovirus
(CMV)-PCR and Epstein–Barr virus (EBV)-PCR were negative.
Serology showed negative IgM and IgG for CMV and negative
IgM and positive IgG for EBV. HIV serology was negative.
The patient had been exposed to measles during a known
measles epidemic in public schools in Austria between January and
April 2008.1 Due to the morbilliform exanthema at the initial
presentation, a measles serology was performed. The serology from
April 9, 2008, 4 days after the appearance of the exanthema, showed
a positive titer formeasles IgM(0.520 and IgG (22.90mIU/ml) (Dade
Behring assay), conﬁrmed by the national reference center for
measles, mumps and rubella (Robert Koch Institut Berlin). About 6
weeks later, on May 23, the IgM titer was still positive and the IgG
titer had decreased (14.90 mIU/ml). Another 11 weeks later, on
August 13, the IgM titer became negative and the IgG titer had
further decreased (6.80 mIU/ml). Measles PCR from oral ﬂuid,
pharynx swab and urine on September 4 were negative.
The patient had been vaccinated for measles during childhood
with a combination vaccine. At that time there were no side effects
of vaccination, nor any symptoms of measles reported. No measles
serology had been done before. As fulminant acute liver failure had
been the indication for transplantation, no serology had been
performed before transplantation.
Liver biopsy (Menghini) was done from the right lobe. Histology
revealed portal inﬂammation and endothelialitis as well as
alteration of the cholangium suggestive of mild acute transplant
rejection (rejection activity index (RAI) score 4).
The diagnosis was liver transplant rejection triggered by a
symptomatic measles infection in a vaccinated, immunosup-
pressed patient, exposed during a measles outbreak in Austria.
1.3. Management
After histological diagnosis of transplant rejection and persis-
tence of elevated liver transaminases and cholestatic parameters,
the patient was given a single course of intravenous methylpred-
nisolone for 3 days (1000 mg four times daily). Tacrolimus was
continued and trough levels were controlled. Fourteen days after
high-dose steroid treatment, the patient was still without any
symptoms, but the liver enzymes were still elevated. Therefore,
mycophenolate mofetil was started at a dose of 1000 mg twice
daily in combination with tacrolimus. After initiation of myco-
phenolate there was a rapid decline of elevated liver parameters
and no side effects or clinical symptoms were reported.
2. Discussion
In March 2008, health authorities identiﬁed a measles
outbreak in the Austrian province of Salzburg in an anthro-posophic school and daycare facility. By mid-April 2008, 207
cases had been reported, most of them from Salzburg. In
addition, about 50 cases with a direct link to the anthroposophic
school were reported in the same period from the province of
Bavaria in Germany. The outbreak was most probably imported
by Swiss nationals who had visited the anthroposophic school in
Salzburg, as the identiﬁed strain showed a 100% sequence
compatibility and identity with the genotype D5 measles virus
from Switzerland.1
Nowadays, two measles vaccinations with a combination MMR
vaccine (mumps–measles–rubella) during childhood are recom-
mended in Germany. The ﬁrst vaccination should be done between
11 and 14months and the second between 15 and 23months after
birth, with 4 weeks between the vaccinations. Ninety percent of
those vaccinated only once show a seroconversion. There is a
known insufﬁcient measles immunity of about 5–10% in Germans
born before 1978. Our patient was born in 1977 and had been
vaccinated only once during childhood.
Antibody titers to MMR have been found to decrease more
rapidly in recipients of liver transplants in the post-transplant
period than in healthy controls.2 It has previously been shown
that 22–55% of patients who had developed antibodies tomeasles
at the time of transplantation had seroreverted in the post-
transplant period.2,3 As serologies in these studies were not
performed at a uniform time-point (6–12 months post-trans-
plantation), timing of seroreversion could not be determined
exactly. Loss of antibodies does not always imply susceptibility to
measles, as cell-mediated immunity is also of great importance.
However, in a study of hepatic transplant recipients, one of three
measles cases was found to be a secondary vaccine failure,
indicating that loss of antibodies can be of clinical signiﬁcance.2
Risk factors for seroreversion in the post-transplant period have
not been identiﬁed, but it has been suggested that it may be more
common in patients who have received only one rather than two
doses of the vaccine.2
Asymptomatic hepatitis as a complication of measles has been
describedwith incidences of 50–80% in young adults4–6 and 5–20%
in children.7
As the elevation of transaminases and cholestatic parameters in
our patientwas higher than previously described and persisted, we
performed a liver biopsy. Histological results showed signs of acute
rejection; there were no apparent morphological changes suspi-
cious for measles affecting the liver cells,8 suggesting that elevated
liver parameters were not due to measles-induced hepatitis alone.
As far as we know this is the ﬁrst described case of liver transplant
rejection triggered by measles infection.
3. Conclusions
Acute measles infection can trigger an acute liver transplant
rejection. Liver transplant patients are at an increased risk
for infection during epidemic outbreaks, even after pre-
transplant vaccination, as immunity may wane over time. As
a consequence of waning immunity to measles in transplant
recipients, exposure should be avoided and the administration
of post-exposure prophylaxis or re-immunization should be
considered. In our and most other transplant programs, live viral
vaccines are not given in the post-transplant period. However,
several groups have reported that post-transplant measles
vaccination could be efﬁcacious and safe.2,9,10 Vaccination
status for measles should be checked and updated in patients
awaiting liver transplantation. Annual monitoring of post-
transplant antibody levels to measles, varicella and rubella
should be considered in solid organ transplant patients.11 If loss
of protective antibody level is detected, re-immunization might
be an option.
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